MetLife, Inc.
MET
$81.07
-$0.34-0.42%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.34% | 23.96% | 2.33% | -1.08% | 7.21% |
| Total Other Revenue | -26.65% | 217.14% | -97.17% | -521.43% | 372.27% |
| Total Revenue | 2.72% | 27.57% | -5.85% | -2.71% | 15.64% |
| Cost of Revenue | 0.61% | 31.24% | 2.00% | -2.24% | 8.62% |
| Gross Profit | 8.43% | 14.02% | -23.02% | -4.24% | 40.22% |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 14.26% | 10.33% | 7.72% | 4.34% | 4.71% |
| Total Operating Expenses | 3.15% | 27.60% | 3.10% | -1.08% | 7.87% |
| Operating Income | -0.99% | 27.09% | -56.24% | -23.94% | 210.73% |
| Income Before Tax | 11.30% | -19.12% | -39.32% | -18.47% | 29.57% |
| Income Tax Expenses | -14.60% | 183.96% | -52.83% | -1.61% | 137.65% |
| Earnings from Continuing Operations | 22.32% | -36.00% | -32.74% | -22.88% | 8.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 560.00% | -75.00% | -700.00% | 14.29% | 37.50% |
| Net Income | 25.40% | -36.35% | -33.23% | -22.94% | 9.00% |
| EBIT | -0.99% | 27.09% | -56.24% | -23.94% | 210.73% |
| EBITDA | -0.98% | 18.69% | -55.67% | -23.54% | 201.24% |
| EPS Basic | 35.72% | -33.88% | -32.51% | -18.94% | 16.46% |
| Normalized Basic EPS | 20.02% | -15.29% | -36.72% | -13.69% | 38.23% |
| EPS Diluted | 35.94% | -34.18% | -32.60% | -18.33% | 16.36% |
| Normalized Diluted EPS | 20.17% | -15.22% | -36.74% | -13.71% | 38.25% |
| Average Basic Shares Outstanding | -4.44% | -5.04% | -4.95% | -5.59% | -5.66% |
| Average Diluted Shares Outstanding | -4.56% | -5.12% | -4.92% | -5.55% | -5.68% |
| Dividend Per Share | 4.13% | 4.13% | 4.13% | 4.13% | 4.81% |
| Payout Ratio | -0.24% | 0.56% | 0.48% | 0.27% | -0.09% |